Company Announcements

SomaLogic established in December 2015 its first continental European SOMAscan Assay Site at VU University Medical Center Amsterdam.

Mimetas received $1.6 million in industry funding to develop an organ-on-a-chip model for neurotoxicity. Mimetas will lead a consortium that includes the Institute for Risk Assessment Sciences and Cellular Dynamics.

PerkinElmer and EpiCypher collaborated to offer AlphaLISA assay kits that measure the binding of the BRD4 and P300 bromodomains to various acetylated histone H2A, H3 or H4 peptides.

Beginning in January, Corning became a global distributor of BioCision products.

TARA Biosystems, which provides physiologically relevant heart-on-a-chip tissue models, raised $2.25 million in seed financing, led by Harris & Harris.

Affymetrix announced a partnership with UK-based Bio-Genesys Diagnostics to offer commercial genotyping services based exclusively on Affymetrix technology.

Kirkstall named Triangle Research Labs as the primary distributor of its 3-D cell fluidic culture system in the US and Canada.

Organovo launched its Samsara Sciences subsidiary, which provides high-quality primary human liver cells for in vivo and in vitro research applications.

N3D announced an OEM agreement with Greiner Bio-One for 3D cell culture and bioprinting.

ATCC licensed CRISPR/Cas9 gene editing technology from the Broad Institute of MIT and Harvard. The first product developed using the technology is the EML4-ALK Fusion-A549 Isogenic Cell Line.

Product Introductions

In December 2015, SGI-DNA launched a suite of Cell Engineering Services for the generation of custom mammalian cell lines for research use.

In January, DiscoveRx released PathHunter Interleukin cell-based assays.

DiscoveRx launched PathHunter Checkpoint Assays for accelerated cancer immunotherapy development.

DiscoveRx released the KILR Cytotoxicity Assay, which is based on a high-sensitivity chemiluminescent method.

Related to its acquisition of Eureka Genomics (see IBO 5/15/15), in January, Affymetrix introduced its Eureka Genotyping Solution for low-cost, low-plex genotyping by sequencing. The firm also released two new array configurations for the Axiom genotyping platform: a 24-sample configuration on the high-density Axiom 96 platform and a 96-sample configuration on the Axiom 384 HT platform.

Clontech Laboratories released the Guide-it CRISPR/Cas9 Gesicle Production System for delivering Cas9/sgRNA ribonucleoprotein complexes to a broad range of cell types.